Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
McDermott MSJ, Browne BC, Conlon NT, O'Brien NA, Slamon DJ, Henry M, Meleady P, Clynes M, Dowling P, Crown J, O'Donovan N.
McDermott MSJ, et al. Among authors: o brien na.
Mol Cancer. 2023 Oct 30;22(1):175. doi: 10.1186/s12943-023-01890-z.
Mol Cancer. 2023.
PMID: 37915024
Free PMC article.
No abstract available.